The cardenolide UNBS1450 is able to deactivate nuclear factor κB–mediated cytoprotective effects in human non–small cell lung cancer cells
Authors:
Open Access
- 1 February 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 5 (2) , 391-399
Abstract
Non–small cell lung cancers (NSCLC) are associated with very dismal prognoses, and adjuvant chemotherapy, including irinotecan, taxanes, platin, and Vinca alkaloid derivatives, offers patients only slight clinical benefits. Part of the chemoresistance of NSCLCs results from the constitutive or anticancer drug-induced activation of the nuclear factor-κB (NF-κB) signaling pathways. The present study shows that human A549 NSCLC cells display highly activated cytoprotective NF-κB signaling pathways. UNBS1450, which is a cardenolide belonging to the same class of chemicals as ouabain and digitoxin, affected the expression and activation status of different constituents of the NF-κB pathways in these A549 tumor cells. The modifications brought about by UNBS1450 led to a decrease in both the DNA-binding capacity of the p65 subunit and the NF-κB transcriptional activity. Using the 3-(4,5-dimethylthiazol-2yl)-dephenyltetrazolium bromide colorimetric assay, we observed in vitro that UNBS1450 was as potent as taxol and SN38 (the active metabolite of irinotecan) in reducing the overall growth levels of the human A549 NSCLC cell line, and was more efficient than platin derivatives, including cisplatin, carboplatin, and oxaliplatin. The chronic in vivo i.p. and p.o. UNBS1450 treatments of human A549 orthotopic xenografts metastasizing to the brains and the livers of immunodeficient mice had a number of significant therapeutic effects on this very aggressive model. [Mol Cancer Ther 2006;5(2):391–9]Keywords
This publication has 45 references indexed in Scilit:
- Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol‐3 kinase pathways in non‐small cell lung cancer cellsInternational Journal of Cancer, 2005
- Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane PermeabilizationJournal of Experimental Medicine, 2004
- Synergistic induction of the Fas (CD95) ligand promoter by Max and NFκB in human non-small lung cancer cellsExperimental Cell Research, 2004
- Up‐regulation of Na+,K+‐ATPase α3‐isoform and down‐regulation of the α1‐isoform in human colorectal cancerFEBS Letters, 2004
- Insulin-like Growth Factor-I Stimulates Dephosphorylation of IκB through the Serine Phosphatase Calcineurin (Protein Phosphatase 2B)Journal of Biological Chemistry, 2000
- The Hallmarks of CancerCell, 2000
- A complex containing βTrCP recruits Ccd34 to catalyse ubiquitination of IκBαFEBS Letters, 1999
- Identification of the Ubiquitin Carrier Proteins, E2s, Involved in Signal-induced Conjugation and Subsequent Degradation of IκBαJournal of Biological Chemistry, 1999
- Ouabain‐resistant non‐small‐cell lung‐cancer CELL LINE SHOWS COLLATERAL SENSITIVITY TO cis‐diamminedichloroplatinum(II) (CDDP)International Journal of Cancer, 1994
- Tissue‐specific expression of Na,K‐ATPase β‐subunit Does β2 expression correlate with tumorigenesis?FEBS Letters, 1991